2-Benzyl-1H-benzimidazole

We are 2-Benzyl-1H-benzimidazole CAS:621-72-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Benzyl-1H-benzimidazole
CAS.NO:   621-72-7
Synonyms:
2-benzyl-1H-benzimidazole
1H-Benzimidazole, 2-(phenylmethyl)-
 
Molecular Formula: C14H12N2
Molecular Weight: 208.25800
 
Physical and Chemical Properties:
Density: 1.193 g/cm3
Boiling point: 453.5ºC at 760 mmHg
Melting point: 187ºC
Flash point: 252.1ºC
Refractive index: 1.680
 
Specification:
Appearance: white or yellow white microfine powder
Purity: >99%
Dechologriseofulvin:Less than 0.60
Dehydrogriseofulvin:Less than 0.15
Substances soluble in light petroleum:NMT 0.20%
Loss on drying:NMT 1.00%
Sulphated ash:NMT 0.20%
Abnormal toxicity:Five mice orals,none of the mice dies within 48h
Assay(anhydrous substance):97.0% to 102.0%
 
Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Store at 4 ° C.Stored in a well-closed container at low temperature, keep away from moisture, heat and light.
Application:Applicationd to treat hypertension.

2-Benzyl-1H-benzimidazole


Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.4-(Trifluoromethoxy)benzenesulfonamide CAS:1513-45-7 Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.3-aminofenilacetileno CAS:54060-30-9 At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.4-FLUORO-2-(TRIFLUOROMETHYL)BENZOIC ACID CAS:141179-72-8 At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.

Related Products
Product Name
4-Chloro-1-methylpiperidine hydrochloride View Details
4-(P-tolylthio)benzophenone View Details
3-Chloro-6-(trifluoromethyl)pyridazine View Details
Methyl 3-chlorosulfonylthiophene-2-carboxylate manufacturer 2,3-Difluoroanisole manufacturer 3,7-Dichloro-8-(dichloromethyl)quinoline manufacturer Triptorelin acetate manufacturer 1-Bromo-2-nitrobenzene manufacturer